{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,28]],"date-time":"2024-07-28T01:31:08Z","timestamp":1722130268727},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2010,10,5]],"date-time":"2010-10-05T00:00:00Z","timestamp":1286236800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1007\/s00277-010-1094-y","type":"journal-article","created":{"date-parts":[[2010,10,4]],"date-time":"2010-10-04T10:10:50Z","timestamp":1286187050000},"page":"395-399","source":"Crossref","is-referenced-by-count":7,"title":["Long-term follow-up of patients with chronic myeloid leukemia having received autologous stem cell transplantation"],"prefix":"10.1007","volume":"90","author":[{"given":"Bj\u00f6rn","family":"Hackanson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cornelius F.","family":"Waller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,10,5]]},"reference":[{"key":"1094_CR1","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1056\/NEJM198105143042004","volume":"304","author":"HP Koeffler","year":"1981","unstructured":"Koeffler HP, Golde DW (1981) Chronic myelogenous leukemia\u2014new concepts. N Engl J Med 304:1201\u20131209","journal-title":"N Engl J Med"},{"issue":"247","key":"1094_CR2","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1126\/science.2406902","volume":"16","author":"GQ Daley","year":"1990","unstructured":"Daley GQ, Van Etten RA, Baltimore D (1990) Induction of chronic myelogenous leukemia in mice by the P210bcr\/abl gene of the Philadelphia chromosome. Science 16(247):824\u2013830","journal-title":"Science"},{"key":"1094_CR3","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1056\/NEJM199904293401706","volume":"340","author":"CL Sawyers","year":"1999","unstructured":"Sawyers CL (1999) Chronic myeloid leukemia. N Engl J Med 340:1330\u20131340","journal-title":"N Engl J Med"},{"key":"1094_CR4","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nm0596-561","volume":"2","author":"BJ Druker","year":"1996","unstructured":"Druker BJ, Tamura S, Buchdunger E, Ohno S, Segal GM, Fanning S et al (1996) Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells. Nat Med 2:561\u2013566","journal-title":"Nat Med"},{"key":"1094_CR5","doi-asserted-by":"crossref","first-page":"6041","DOI":"10.1200\/JCO.2009.25.0779","volume":"27","author":"M Baccarani","year":"2009","unstructured":"Baccarani M, Cortes J, Pane F, Niederwieser D, Saglio G, Apperley J et al (2009) Chronic myeloid leukemia: an update of concepts and management recommendations of European LeukemiaNet. J Clin Oncol 27:6041\u20136051","journal-title":"J Clin Oncol"},{"key":"1094_CR6","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1056\/NEJMe030009","volume":"348","author":"K Peggs","year":"2003","unstructured":"Peggs K, Mackinnon S (2003) Imatinib mesylate\u2014the new gold standard for treatment of chronic myeloid leukemia. N Engl J Med 348:1048\u20131050","journal-title":"N Engl J Med"},{"key":"1094_CR7","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1038\/leu.2009.38","volume":"23","author":"A Hochhaus","year":"2009","unstructured":"Hochhaus A, O\u2019Brien SG, Guilhot F, Druker BJ, Branford S, Foroni L et al (2009) Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia. Leukemia 23:1054\u20131061","journal-title":"Leukemia"},{"key":"1094_CR8","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1016\/S0140-6736(94)92589-5","volume":"343","author":"PB McGlave","year":"1994","unstructured":"McGlave PB, De Fabritiis P, Deisseroth A, Goldman J, Barnett M, Reiffers J et al (1994) Autologous transplants for chronic myelogenous leukaemia: results from eight transplant groups. Lancet 343:1486\u20131488","journal-title":"Lancet"},{"key":"1094_CR9","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1182\/blood.V89.8.2623","volume":"89","author":"R Bhatia","year":"1997","unstructured":"Bhatia R, Verfaillie CM, Miller JS, McGlave PB (1997) Autologous transplantation therapy for chronic myelogenous leukemia. Blood 89:2623\u20132634","journal-title":"Blood"},{"key":"1094_CR10","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1046\/j.1365-2141.1998.00964.x","volume":"103","author":"CF Waller","year":"1998","unstructured":"Waller CF, Heinzinger M, Rosenstiel A, Lange W (1998) Mobilization and transplantation of Philadelphia chromosome-negative peripheral blood progenitor cells in patients with CML. Br J Haematol 103:227\u2013234","journal-title":"Br J Haematol"},{"key":"1094_CR11","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/sj.leu.2400960","volume":"12","author":"M Heinzinger","year":"1998","unstructured":"Heinzinger M, Waller CF, Rosenstiel A, Scheid S, Burger KJ, Lange W (1998) Quality of IL-3 and G-CSF-mobilized peripheral blood stem cells in patients with early chronic phase CML. Leukemia 12:333\u2013339","journal-title":"Leukemia"},{"key":"1094_CR12","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1111\/j.1365-2141.1994.tb06755.x","volume":"87","author":"G Bergamaschi","year":"1994","unstructured":"Bergamaschi G, Podest\u00e0 M, Frassoni F, Rosti V, Carella AM, Saglio G et al (1994) Restoration of normal polyclonal haemopoiesis in patients with chronic myeloid leukaemia autografted with Ph-negative peripheral stem cells. Br J Haematol 87:867\u2013870","journal-title":"Br J Haematol"},{"key":"1094_CR13","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1200\/JCO.1997.15.4.1575","volume":"15","author":"AM Carella","year":"1997","unstructured":"Carella AM, Cunningham I, Lerma E, Dejana A, Benvenuto F, Podest\u00e0 M et al (1997) Mobilization and transplantation of Philadelphia-negative peripheral-blood progenitor cells early in chronic myelogenous leukemia. J Clin Oncol 15:1575\u20131582","journal-title":"J Clin Oncol"},{"key":"1094_CR14","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S0037-1963(03)70044-4","volume":"40","author":"AM Carella","year":"2003","unstructured":"Carella AM, Beltrami G, Corsetti MT (2003) Autografting in chronic myeloid leukemia. Semin Hematol 40:72\u201378","journal-title":"Semin Hematol"},{"key":"1094_CR15","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ctrv.2006.10.002","volume":"33","author":"CML Autograft Trials Collaboration","year":"2007","unstructured":"CML Autograft Trials Collaboration (2007) Autologous stem cell transplantation in chronic myeloid leukaemia: a meta-analysis of six randomized trials. Cancer Treat Rev 33:39\u201347","journal-title":"Cancer Treat Rev"},{"key":"1094_CR16","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1053\/j.seminhematol.2007.08.003","volume":"44","author":"E Olavarria","year":"2007","unstructured":"Olavarria E (2007) Autologous stem cell transplantation in chronic myeloid leukemia. Semin Hematol 44:252\u2013258","journal-title":"Semin Hematol"},{"key":"1094_CR17","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1111\/j.1537-2995.2005.00175.x","volume":"45","author":"P Perseghin","year":"2005","unstructured":"Perseghin P, Gambacorti-Passerini C, Tornaghi L, Dassi M, Pioltelli P, Parma M et al (2005) Peripheral blood progenitor cell collection in chronic myeloid leukemia patients with complete cytogenetic response after treatment with imatinib mesylate. Transfusion 45:1214\u20131220","journal-title":"Transfusion"},{"key":"1094_CR18","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1159\/000084445","volume":"113","author":"B Simonsson","year":"2005","unstructured":"Simonsson B, Oberg G, Bjoreman M, Bjorkholm M, Carneskog J, Karlsson K et al (2005) Intensive treatment and stem cell transplantation in chronic myelogenous leukemia: long-term follow-up. Acta Haematol 113:155\u2013162","journal-title":"Acta Haematol"},{"key":"1094_CR19","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1046\/j.1365-2141.2003.04756.x","volume":"124","author":"KA Kreuzer","year":"2004","unstructured":"Kreuzer KA, Kl\u00fchs C, Baskaynak G, Movassaghi K, D\u00f6rken B, le Coutre P (2004) Filgrastim-induced stem cell mobilization in chronic myeloid leukaemia patients during imatinib therapy: safety, feasibility and evidence for an efficient in vivo purging. Br J Haematol 124:195\u2013199","journal-title":"Br J Haematol"},{"key":"1094_CR20","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/sj.leu.2402917","volume":"17","author":"CH Hui","year":"2003","unstructured":"Hui CH, Goh KY, White D, Branford S, Grigg A, Seymour JF et al (2003) Successful peripheral blood stem cell mobilisation with filgrastim in patients with chronic myeloid leukaemia achieving complete cytogenetic response with imatinib, without increasing disease burden as measured by quantitative real-time PCR. Leukemia 17:821\u2013828","journal-title":"Leukemia"},{"key":"1094_CR21","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1038\/sj.leu.2403170","volume":"17","author":"P Coutre le","year":"2003","unstructured":"le Coutre P, Kreuzer KA, Massenkeil G, Baskaynak G, Zschieschang P, Genvresse I et al (2003) Autologous peripheral blood stem cell transplantation of stem cells harvested in imatinib-induced complete cytogenetic remission: an example of in vivo purging in CML. Leukemia 17:2525\u20132526","journal-title":"Leukemia"},{"key":"1094_CR22","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1038\/sj.leu.2402565","volume":"16","author":"T Fischer","year":"2002","unstructured":"Fischer T, Reifenrath C, Hess GR, Corsetti MT, Kreil S, Beck J et al (2002) Safety and efficacy of STI-571 (imatinib mesylate) in patients with bcr\/abl-positive chronic myelogenous leukemia (CML) after autologous peripheral blood stem cell transplantation (PBSCT). Leukemia 16:1220\u20131228","journal-title":"Leukemia"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-010-1094-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-010-1094-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-010-1094-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,12]],"date-time":"2020-06-12T10:10:13Z","timestamp":1591956613000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-010-1094-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10,5]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["1094"],"URL":"https:\/\/doi.org\/10.1007\/s00277-010-1094-y","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10,5]]}}}